Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck

We previously reported that nab-paclitaxel-based induction chemotherapy (IC) and concurrent chemoradiotherapy resulted in low relapse rates (13%) and excellent survival in head and neck squamous cell carcinoma (HNSCC). We compare the disease-specific survival (DSS) and overall survival (OS) between...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Med
Auteurs principaux: Schell, Amy, Ley, Jessica, Wu, Ningying, Trinkaus, Kathryn, Wildes, Tanya Marya, Michel, Loren, Thorstad, Wade, Gay, Hiram, Lewis, James, Rich, Jason, Diaz, Jason, Paniello, Randal C, Nussenbaum, Brian, Adkins, Douglas R
Format: Artigo
Langue:Inglês
Publié: BlackWell Publishing Ltd 2015
Sujets:
Cancer Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4402061/
https://ncbi.nlm.nih.gov/pubmed/25619559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.382
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires